Sharechat Logo


Monday 23rd September 2013

Text too small?

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced at its investor day in Sydney today the introduction of the F&P Pilairo™ Q nasal pillows mask for the treatment of obstructive sleep apnea (OSA).

The Pilairo Q has been designed with a focus on quietness and versatility and retains the unique advantages customers have come to appreciate with the Pilairo. These include the effective seal as a result of the unique air-pillow which self inflates with CPAP flow and the one-size-fits-most, adjustment-free, Stretchwise headgear.

In addition, the Pilairo Q offers ultra-quiet use and minimal draft to eliminate any partner disturbance. Users also now have a choice of headgear, with the addition of an alternative, adjustable version that fits a wider range of patients.

“Pilairo has been very well received by customers and Pilairo Q builds on that success to provide additional options and benefits that enhance overall therapy performance including quieter use, less draft and a greater range of fit” commented Michael Daniell, Fisher & Paykel Healthcare’s Chief Executive Officer.

The Pilairo Q nasal pillows mask will be introduced to Australia, Canada and the United States in the coming weeks. “Pilairo Q further strengthens our premium mask offering, which includes the recently launched Eson nasal mask, and Simplus full face mask, both of which have performed exceptionally well for our customers”, concluded Mr Daniell.

About Fisher & Paykel Healthcare

Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. 

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins
Fisher & Paykel Healthcare